Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 29 most recent Form 4 transactions.
| Jul 9 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 10,000 | $81.49 | $814.9K | +18.3% | Open the original filing on SEC.gov |
| Jun 29 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 1,690 | — | — | — | Open the original filing on SEC.gov |
| Jun 29 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 8,110 | — | — | — | Open the original filing on SEC.gov |
| Jun 29 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 1,690 | $170.81 | $288.7K | -3.0% | Open the original filing on SEC.gov |
| Jun 29 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 1,690 | $81.49 | $137.7K | +3.1% | Open the original filing on SEC.gov |
| Jun 29 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 8,110 | $170.03 | $1.4M | -12.9% | Open the original filing on SEC.gov |
| Jun 29 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 8,110 | $81.49 | $660.9K | +14.8% | Open the original filing on SEC.gov |
| Jun 26 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 200 | — | — | — | Open the original filing on SEC.gov |
| Jun 26 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 200 | $169.57 | $33.9K | -0.4% | Open the original filing on SEC.gov |
| Jun 26 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 200 | $81.49 | $16.3K | +0.4% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 6,124 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 34,909 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,083 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,017 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | GGIFT | 365 | — | — | -0.7% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 5,378 | $124.12 | $667.5K | -8.9% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT | 9,968 | — | — | +19.7% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 1,124 | $124.12 | $139.5K | -2.2% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 2,083 | — | — | +4.2% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 1,089 | $124.12 | $135.2K | -2.1% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 2,017 | — | — | +4.2% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,792 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | FTAX | 967 | $123.10 | $119K | -1.9% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER | 1,792 | — | — | +3.8% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,373 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | FTAX | 1,335 | $136.06 | $181.6K | -2.7% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER | 2,373 | — | — | +5.1% | Open the original filing on SEC.gov |